Beigene logo

BGNE - Beigene News Story

$311.97 -2.0  -0.6%

Last Trade - 07/05/21

Sector
Healthcare
Size
Large Cap
Market Cap £20.83bn
Enterprise Value £17.86bn
Revenue £222.5m
Position in Universe 446th / 6854

BRIEF-Beigene Launches Brukinsa In Canada For Patients With Waldenström’s Macroglobulinemia

Thu 8th April, 2021 12:11pm
April 8 (Reuters) - Beigene Ltd  6160.HK :
    * BEIGENE LAUNCHES BRUKINSA® (ZANUBRUTINIB) IN CANADA FOR
PATIENTS
WITH WALDENSTRÖM’S MACROGLOBULINEMIA
    * BEIGENE LTD - CANADIAN PATIENTS NOW HAVE ACCESS TO
MYBEIGENE(®)
PATIENT SUPPORT PROGRAM.
    * BEIGENE LTD - BRUKINSA IS NOW COMMERCIALLY AVAILABLE IN
CANADA
FOLLOWING APPROVAL IN MARCH.

Source text for Eikon:  ID:nBw6yvBzxa 
Further company coverage:  6160.HK 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.